Kırşehir Ahi Evran University, Physical Therapy and Rehabilitation Center, Cardiopulmonary Unit
Kırşehir, Merkez, 40100, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT06769386
The aim of this study is to investigate respiratory muscle strength, respiratory muscle endurance, muscle oxygenation, upper extremity and lower extremity exercise capacity in rheumatoid arthritis patients compared with healthy individuals.
Interested in participating?
Request Info18 year–65 year
All sexes
Observational
Kırşehir, Merkez, 40100, Turkey (Türkiye)
Location status: Recruiting
Rheumatoid arthritis (RA) is a chronic progressive autoimmune disease of unknown etiology with symmetric erosive synovitis and multisystem involvement. The disease causes significant long-term morbidity, reduced functional capacity, and increased mortality rates. Patients with rheumatoid arthritis avoid physical activity due to pain and fatigue. Despite the advances in pharmacological treatments in recent years, functional losses due to rheumatic diseases the resulting deterioration in quality of life, and loss of work continue. Physical inactivity is known to have detrimental effects on the cardiovascular and pulmonary systems by reducing muscle strength and aerobic capacity. The physiological reasons underlying skeletal muscle oxygenation that may cause muscle dysfunction in rheumatoid arthritis have not been investigated. In these patients, decreased arterial oxygen may reduce exercise capacity and cause muscle deoxygenation.
In rheumatoid arthritis patients, decreases in respiratory muscle strength, lung volumes, oxygen consumption, and six minute walk test distance cause cardiopulmonary deconditioning. Decreased exercise capacity increases the risk of cardiovascular disease and causes mortality in patients with RA.
This study aimed to, the effects of respiratory muscle strength, respiratory muscle endurance, upper and lower extremity muscle oxygenation, and upper and lower extremity exercise capacity in patients with stable disease activity.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Rheumatoid Arthritis Group
Inclusion criteria
Exclusion criteria
Control Group
Inclusion criteria
Exclusion criteria
Time frame: First day
An electronic mouth pressure measuring device that complies with American Thoracic Society and European Respiratory Society criteria will be used to assess respiratory muscle strength.
Time frame: First day
The incremental threshold workload test will be used to assess respiratory muscle endurance.The PowerBreathe Wellness® (HaB International Ltd. Southam, United Kingdom) inspiratory muscle training device will be used in the incremental threshold load test.
Time frame: First and second day
Muscle oxygen level of quadriceps femoris and deltoid muscles will be measured using Moxy® monitor (Moxy, Fortiori Design LLC, Minnesota, USA) before, during and after the six-minute walk test and six-minute peg-board and ring test.
Time frame: First and second day
Total hemoglobin level of quadriceps femoris and deltoid muscles will be measured using Moxy® monitor (Moxy, Fortiori Design LLC, Minnesota, USA) before, during and after the six-minute walk test and six-minute peg-board and ring test.
Time frame: First day and second day
The six-minute walk test will be performed according to American Thoracic Society criteria to evaluate functional exercise capacity.
Time frame: First day and second day
The six-minute peg board and ring test will be used to assess upper extremity exercise capacity.
Contact information is provided by the study sponsor or research team.
Kirsehir Ahi Evran Universitesi
Other
Investigation of Respiratory Muscle Strength, Respiratory Muscle Endurance and Muscle Oxygenation in Patients With Rheumatoid Arthritis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07207954
Arthritis, Arthritis, Rheumatoid
Melbourne, Australia
View Trial DetailsNCT07295847
Arthritis, Arthritis, Rheumatoid
Tucson, Arizona, United States
View Trial DetailsNCT07137598
Arthritis, Arthritis, Rheumatoid
Peoria, Arizona, United States
View Trial DetailsNCT07620392
Arthritis, Arthritis, Rheumatoid
Tamarac, Florida, United States
View Trial Details